Immunological Aspects of Good-quality Dysplasia of Mammary Glands at Women of Reproductive Age

##plugins.themes.bootstrap3.article.main##

С. Є. Гладенко

Abstract

The objective: to study modern immunologic aspects of good-quality dysplasia of mammary glands at women of reproductive age.

Materials and methods. Were surveyed 90 patients aged from 22 till 45 years which are divided into 3 groups on 30 women: 1 group (group of control) – the woman without pathology in mammary glands. The 2nd group included patients with diffuse form of good-quality dysplasia of mammary glands. The 3rd group was made by patients with a nodal form of a good-quality dysplasia of mammary glands. The complex the researches included clinical, immunologic and statistical methods.

Results. Results of the conducted researches testify that it is possible to refer existence of chronic extragenital diseases, smoking, an early menarche to risk factors of development of a good-quality dysplasia of mammary glands, disturbances of a menstrual cycle, hysteromyoma and an adenomyosis, an artificial or spontaneous abortion. The research conducted by us proved that immunologic determinants play an essential role and are risk factors and an initial link of pathogenesis of benign pathology of mammary glands.

Conclusion. The received results need to be considered when developing algorithm of diagnostic and treatment-and-prophylactic actions.

##plugins.themes.bootstrap3.article.details##

How to Cite
Гладенко, С. Є. (2019). Immunological Aspects of Good-quality Dysplasia of Mammary Glands at Women of Reproductive Age. Family Medicine, (5-6), 144–146. https://doi.org/10.30841/2307-5112.5-6.2019.194843
Section
Obstetrics and gynecology
Author Biography

С. Є. Гладенко, P.L. Shupyk National Medical Academy of Postgraduate Education

Svitlana Ye. Gladenko,

Department of Obstetrics, Gynecology and Perinatology

References

Шурпяк С.О., Пирогова В.І., 2018. Репродуктивне здоров’я і коморбідні стани. Аспекти діагностики, лікування і реабілітації. – Львів: Простір-М: 224.

Hammad A.E., 2016. Women and health security. Wld Hlth Statist. Quart. 49(2):74-7.

Вольфф М. фон, Штуте П., 2017. Гинекологическая эндокринология и репродуктивная медицина, пер. с нем. под ред. Е.Н. Андреевой. – М.: МЕД-пресс-информ: 512.

Радзинский В.Е., 2011. Репродуктивное здоровье: Учеб. пособие. – М.: РУДН: 727.

Запорожан В.М. та ін., 2013. Акушерство та гінекологія: у 4-х т.: національний підручник. – К.: ВСВ Медицина: 1032.

Корнацька А.Г., Татарчук Т.Ф., Дубенко О.Д. 2017. Безплідність та доброякісні захворювання молочної залози. – К.: 271.

Бабаева Н.А., Ашрафян Л.А., Антонова И.Б., Алешикова О.И., Ивашина С.В., 2017. Роль гормональных нарушений в канцерогенезе опухолей женской репродуктивной системы // Акушерство и гинекология: новости, мнения, обучение. 1:76-82.